FHA
EBS icon

Flagship Harbor Advisors’s Emergent Biosolutions EBS Stock Holding History

Flagship Harbor Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$25 – 1107
2025
Q4 		$25 Buy
+2
New +$21 ﹤0.01% 2256
2020
Q4 		– Sell
-236
Closed -$24K – 842
2020
Q3 		$24K Buy
236
+136
+136% +$14.7K ﹤0.01% 1078
2020
Q2 		$7K Buy
+100
New +$7.45K ﹤0.01% 1466

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Flagship Harbor Advisors's EBS Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Emergent Biosolutions (EBS) in Q1 2026, closing a stake of 2 shares — an estimated $25 sold.

Flagship Harbor Advisors first reported a position in EBS in Q2 2020 and held it in 3 quarters. The position peaked at $24K in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Emergent Biosolutions position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 2 Emergent Biosolutions shares in Q1 2026, an estimated $25.
  • Flagship Harbor Advisors first reported a position in Emergent Biosolutions in Q2 2020 and held it in 3 quarters.
  • Flagship Harbor Advisors's Emergent Biosolutions position peaked at $24K in Q3 2020.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.